Machine Learning for Early Diagnosis of Endometriosis(MLEndo)

Sponsor
Semmelweis University (Other)
Overall Status
Recruiting
CT.gov ID
NCT06147687
Collaborator
University of Aarhus (Other)
10,000
2
36
5000
139

Study Details

Study Description

Brief Summary

The project aims to create a large prospective data bank using the Lucy medical mobile application and collect and analyze patient profiles and structured clinical data with artificial intelligence. In addition, authors will investigate the association of removed or restricted dietary components with quality of life, pain, and central sensitization.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Self reported data collection

Detailed Description

Introduction: Endometriosis is a complex and chronic disease that affects ∼176 million women of reproductive age and remains largely unresolved. It is defined by the presence of endometrium-like tissue outside the uterus and is commonly associated with chronic pelvic pain, infertility, and decreased quality of life. Despite numerous proposed screening and triage methods such as biomarkers, genomic analysis, imaging techniques, and questionnaires to replace invasive diagnostic laparoscopy, none have been widely adopted in clinical practice.

. Despite the availability of various screening methods (e.g., biomarkers, genomic analysis, imaging techniques) that are intended to replace the need for invasive diagnostic laparoscopy, the time to diagnosis remains in the range of 4 to 11 years. Aims: The project aims to create a large prospective data bank using the Lucy medical mobile application and collect and analyze patient profiles and structured clinical data with artificial intelligence. In addition, authors will investigate the association of removed or restricted dietary components with quality of life, pain, and central sensitization. Methods: A Baseline and Longitudinal Questionnaire in the Lucy app collects self-reported information on symptoms related to endometriosis, socio-demographics, mental and physical health, nutritional, and other lifestyle factors. 5,000 women with endometriosis and 5,000 women in a control group will be enrolled and followed up for one year. With this information, any connections between symptoms and endometriosis will be analyzed with machine learning. Conclusions: Authors can develop a phenotypic description of women with endometriosis by linking the collected data with existing registry-based information on endometriosis diagnosis, healthcare utilization, and big data approach. This may help to achieve earlier detection of endometriosis with pelvic pain and significantly reduce the current diagnostic delay. Additionally, authors can identify nutritional components that may worsen the quality of life and pain in women with endometriosis; thus, authors can create evidence-based dietary recommendations.

Keywords: Endometriosis, Machine learning, Non-invasive diagnosis, Diet

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
10000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
FEMaLe: The Use of Machine Learning for Early Diagnosis of Endometriosis Based on Patient Self-reported Data - Study Protocol of a Multicenter Trial
Actual Study Start Date :
Jan 1, 2022
Anticipated Primary Completion Date :
Dec 31, 2024
Anticipated Study Completion Date :
Dec 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Patients with endometriosis and Healthy controls

5 000 people with endometriosis will be enrolled and followed up for 1one year. To participate in the study, the women must meet the inclusion criteria.

Diagnostic Test: Self reported data collection
ML assessement of colleceted data
Other Names:
  • ML assessement
  • Control

    5 000 people in a control group will be enrolled and followed up for 1one year. To participate in the study, the women must meet the inclusion criteria.

    Diagnostic Test: Self reported data collection
    ML assessement of colleceted data
    Other Names:
  • ML assessement
  • Outcome Measures

    Primary Outcome Measures

    1. Patient- profiling using the Lucy app [24 month]

      Establish a comprehensive and extensive prospective big data repository using the Lucy app. This initiative aims to identify unique clinical cohorts by leveraging various factors such as digital footprints, symptoms, patient experiences, comorbidities, clinical severity, and lifestyle patterns. By employing Using ML for big data analysis, authors can build patient profiles and structured clinical data that facilitate the early detection of endometriosis with pelvic pain. Self-reported data of the participants will be measured as follows: Evaluating the quality of life using the 5-level EQ-5D (EQ-5D-5L) Endometriosis Health Profile 5 (EHP-5) . Pain scores using the Visual Analogue Scale (VAS) . Central pain sensitization using the short version of Central Sensitization Inventory (CSI-9)

    Secondary Outcome Measures

    1. Impact of diet and lifestyle on the development of endometriosis [24 month]

      Additionally, authors can identify nutritional components that may worsen the quality of life and pain in women with endometriosis; thus, they can create evidence-based dietary recommendations. The changes in quality of life will be assessed by using Self-reported data of the participants will be measured as follows: Change From Baseline in Pain Scores on the Visual Analog Scale at 12 months. Changes from baseline values on EHP5 at 12 months

    Other Outcome Measures

    1. Economical burden of endometriosis [24 month]

      Economical burden taking into account the cost of diet and healthcare use. The exact cost of endometriosis related diet will be reported per month in EUR.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    14 Years to 45 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Women in reproductive age

    • 5000 patients with endometriosis

    • 5000 patients without endometriosis

    Exclusion Criteria:
    • Ongoing pregnancy

    • Malignant condition of ovary/uterus/breast

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Bokor Attila Budapest Hungary 1028
    2 Semmelweis University Budapest Hungary 1088

    Sponsors and Collaborators

    • Semmelweis University
    • University of Aarhus

    Investigators

    • Principal Investigator: Attila Bokor, Semmelweis University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Semmelweis University
    ClinicalTrials.gov Identifier:
    NCT06147687
    Other Study ID Numbers:
    • Semmelweis
    First Posted:
    Nov 28, 2023
    Last Update Posted:
    Nov 28, 2023
    Last Verified:
    Sep 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Semmelweis University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 28, 2023